Results 11 to 20 of about 2,224,563 (253)

Immune Resistance in Lung Adenocarcinoma [PDF]

open access: yesCancers, 2021
Lung cancer is the leading cancer killer worldwide, imposing grievous challenges for patients and clinicians. The incidence of lung adenocarcinoma (LUAD), the main histologic subtype of lung cancer, is still increasing in current-, ex-, and even non-smokers, whereas its five-year survival rate is approximately 15% as the vast majority of patients ...
Magda Spella, Georgios T. Stathopoulos
openaire   +4 more sources

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

open access: yesCell, 2020
Summary To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic opportunities, we performed comprehensive proteogenomic characterization of 110 tumors and 101 matched normal adjacent tissues (NATs) incorporating genomics ...
Michael A Gillette   +2 more
exaly   +2 more sources

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

open access: yesCell, 2020
Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the disease's biology and accelerated targeted therapy. However, the proteomic characteristics of LUAD remain poorly understood.
Jun-Yu Xu, Xiang Wang, Yousheng Mao
exaly   +2 more sources

International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

open access: yesJournal of Thoracic Oncology, 2011
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To address advances in oncology, molecular biology, pathology, radiology, and surgery of lung adenocarcinoma, an international multidisciplinary classification was sponsored ...
William D Travis   +2 more
exaly   +2 more sources

A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

open access: yesJournal of Thoracic Oncology, 2020
Introduction: A grading system for pulmonary adenocarcinoma has not been established. The International Association for the Study of Lung Cancer pathology panel evaluated a set of histologic criteria associated with prognosis aimed at establishing a ...
André L Moreira   +2 more
exaly   +2 more sources

Hepatoid Adenocarcinoma of the Lung [PDF]

open access: yesTechnology in Cancer Research & Treatment, 2021
Hepatoid adenocarcinoma of the lung (HAL) is an comparatively rare malignant tumor originating from the lung with shorter survival. HAL morphologically and pathologically exhibits hepatocellular carcinoma (HCC)-like characteristics, while its clinical features resemble pulmonary adenocarcinoma.
Meihui Li, Ying Fan, Hongyang Lu
openaire   +3 more sources

Lung adenocarcinoma promotion by air pollutants

open access: yesNature, 2023
A complete understanding of how exposure to environmental substances promotes cancer formation is lacking. More than 70 years ago, tumorigenesis was proposed to occur in a two-step process: an initiating step that induces mutations in healthy cells ...
William Hill   +326 more
semanticscholar   +1 more source

STING inhibits the reactivation of dormant metastasis in lung adenocarcinoma

open access: yesNature, 2023
STING signalling is activated in metastatic cancer cells that exit from an immune-evasive dormant state, blocking their progression and cancer relapse. Metastasis frequently develops from disseminated cancer cells that remain dormant after the apparently
Jing Hu   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy